Down-regulation of GPX 3 is associated with favorable / intermediate karyotypes in de novo acute myeloid leukemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a DNA Methylome Profile of Esophageal Squamous Cell Carcinoma and Potential Plasma Epigenetic Biomarkers for Early Diagnosis

  2014cited by this paper
• Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer.

  2014cited by this paper
• Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.

  2014cited by this paper
• APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.

  2014cited by this paper
• Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma

  2014cited by this paper
• Promoter Hypermethylation and Suppression of Glutathione Peroxidase 3 Are Associated with Inflammatory Breast Carcinogenesis

  2014cited by this paper
• Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

  2013influential reference
• Tumor and Stem Cell Biology Tumor Suppressor Function of the Plasma Glutathione Peroxidase Gpx 3 in Colitis-Associated Carcinoma

  2013cited by this paper
• Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer

  2013cited by this paper
• Glutathione peroxidases.

  2013cited by this paper
• Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia.

  2013cited by this paper
• RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia.

  2013cited by this paper
• A role for GPx3 in activity of normal and leukemia stem cells

  2012cited by this paper
• Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer.

  2012cited by this paper
• IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome

  2012cited by this paper
• Silencing of Glutathione Peroxidase 3 through DNA Hypermethylation Is Associated with Lymph Node Metastasis in Gastric Carcinomas

  2012cited by this paper
• U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

  2012cited by this paper
• Identification of GPX3 Epigenetically Silenced by CpG Methylation in Human Esophageal Squamous Cell Carcinoma

  2011cited by this paper
• Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

  2011cited by this paper
• Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

  2011cited by this paper
• GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response.

  2011cited by this paper
• Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma

  2010cited by this paper
• Glutathione peroxidases in different stages of carcinogenesis.

  2009cited by this paper
• Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma.

  2008cited by this paper
• Molecular genetic pathways as therapeutic targets in acute myeloid leukemia.

  2008cited by this paper
• Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.

  2007cited by this paper
• Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

  2007cited by this paper
• The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.

  2007cited by this paper
• Acute myeloid leukaemia.

  2006cited by this paper
• Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.

  2005cited by this paper
• Adult acute myeloid leukaemia.

  2004cited by this paper
• Tumor suppressor genes in normal and malignant hematopoiesis

  2002cited by this paper
• Oncogenic transcription factors in the human acute leukemias.

  1997cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper

• No citing papers are available for this paper.